Some years ago the people behind Parx Materials recognised a growing demand for plastics with antimicrobial and antiviral properties and from their expertise they knew that the available solutions were not suitable for large-scale adoption because of their possible harmful effects on humans, animals or the environment as a whole. They had foreseen the dangers, insecurities and disadvantages of these solutions.

Over four years of dedicated biomimetic research has been invested to create a 100% safe and biocompatible technology to inhibit the growth of bacteria on the surface of plastic with the use of a biomimetic approach in the design and engineering of the materials. The discoveries and inventions done during this research are truly unique and groundbreaking. A team of 11 professors, scientists and researchers with decades of experience in the field of nano- and biotechnologies and skilled in chemical analyses and chemical-physical and microbial analyses have been working together with a renown European university for chemistry. The result is a worldwide patented innovation for highly effective plastics with an antibacterial/antimicrobial effectiveness rate of Log 3/99.9% and higher measured according to ISO 22196, and most of all: safe. Products and parts made with the aid of Parx Materials' Saniconcentrate™ are safe for humans, safe for animals and safe for the environment.